PlainRecalls
FDA Drug Moderate Class II Completed

Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, 100 count bottles, Rx Only Manufactured by: Apotex, Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326 NDC 60505-0260-1

Reported: June 24, 2020 Initiated: May 27, 2020 #D-1303-2020

Product Description

Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, 100 count bottles, Rx Only Manufactured by: Apotex, Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326 NDC 60505-0260-1

Reason for Recall

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above acceptable intake levels

Details

Recalling Firm
Apotex Inc.
Units Affected
305,963 bottles
Distribution
Nationwide.
Location
North York

Frequently Asked Questions

What product was recalled?
Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, 100 count bottles, Rx Only Manufactured by: Apotex, Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326 NDC 60505-0260-1. Recalled by Apotex Inc.. Units affected: 305,963 bottles.
Why was this product recalled?
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above acceptable intake levels
Which agency issued this recall?
This recall was issued by the FDA Drug on June 24, 2020. Severity: Moderate. Recall number: D-1303-2020.